Table 2.

SLE and RA prevalence in women 18+ years and all patients with breast cancer.

CohortPatients in CohortPatients with SLESLE PrevalencePatients with RARA Prevalence
All women 18+ yrs12,087,76046,5900.39%117,5800.97%
Patients with breast cancer238,88016600.69%59202.48%
  • RA: rheumatoid arthritis; SLE: systemic lupus erythematosus.